113 related articles for article (PubMed ID: 17209432)
1. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
[TBL] [Abstract][Full Text] [Related]
2. Silencing of c-myc expression in tumor cells by siRNA.
Kabilova TO; Chernolovskaya EL; Vladimirova AV; Vlassov VV
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):867-72. PubMed ID: 15560074
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA.
Kabilova TO; Chernolovskaya EL; Vladimirova AV; Vlassov VV
Oligonucleotides; 2006; 16(1):15-25. PubMed ID: 16584292
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs.
Hung L; Kumar V
FEBS Lett; 2004 Feb; 560(1-3):210-4. PubMed ID: 14988024
[TBL] [Abstract][Full Text] [Related]
5. Arrest of cancer cell proliferation by dsRNAs.
Kabilova TO; Vladimirova A'; Chernolovskaya EL; Vlassov VV
Ann N Y Acad Sci; 2006 Dec; 1091():425-36. PubMed ID: 17341633
[TBL] [Abstract][Full Text] [Related]
6. [c-myc gene silencing in K562 cells with RNA interference].
Yue F; Ma WL; Song YB; Shi R; Zhang B; Zheng WL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):647-50. PubMed ID: 15958299
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
[TBL] [Abstract][Full Text] [Related]
9. Potential design rules and enzymatic synthesis of siRNAs.
Sioud M; Leirdal M
Methods Mol Biol; 2004; 252():457-69. PubMed ID: 15017071
[TBL] [Abstract][Full Text] [Related]
10. Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma.
Hong J; Zhao Y; Huang W
Biochem Biophys Res Commun; 2006 Sep; 348(2):600-5. PubMed ID: 16890193
[TBL] [Abstract][Full Text] [Related]
11. Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35).
Sarkar D; Park ES; Fisher PB
Cell Death Differ; 2006 Sep; 13(9):1541-53. PubMed ID: 16410805
[TBL] [Abstract][Full Text] [Related]
12. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
[TBL] [Abstract][Full Text] [Related]
13. DEQOR: a web-based tool for the design and quality control of siRNAs.
Henschel A; Buchholz F; Habermann B
Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W113-20. PubMed ID: 15215362
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligodeoxynucleoside methylphosphonate inhibition of mouse c-myc p65 protein expression in E mu-c-myc transgenic mice.
Wickstrom E; Bacon TA; Wickstrom EL; Werking CM; Palmiter RD; Brinster RL; Sandgren EP
Nucleic Acids Symp Ser; 1991; (24):151-4. PubMed ID: 1841270
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
16. Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
Zhang L; Wali A; Ramana CV; Rishi AK
Cancer Res; 2007 Nov; 67(21):10198-206. PubMed ID: 17974960
[TBL] [Abstract][Full Text] [Related]
17. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs.
Stierlé V; Laigle A; Jollès B
Biochem Pharmacol; 2005 Nov; 70(10):1424-30. PubMed ID: 16214115
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
19. A structure-activity relationship study of siRNAs with structural variations.
Chang CI; Hong SW; Kim S; Lee DK
Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
[TBL] [Abstract][Full Text] [Related]
20. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
